$SPEX AIkido Pharma Inc. Insider Trading
Get free email notifications about insider trading in AIkido Pharma Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AIkido Pharma Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in AIkido Pharma Inc. for free.
CIK Number: 0000012239
IRS Number: 520849320
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Trading Symbol: SPEX
Company Address: ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK 10020
Phone number: 347-321-7646
Former name: BIOSPHERICS RESEARCH INC, date of change: 1972-04-04
Former name: BIOSPHERICS INC, date of change: 1992-07-03
Former name: SPHERIX INC, date of change: 2001-08-15
Former name: Aikido Pharma Inc., date of change: 2020-03-17
Market Capitalization: $5.74M
Prev close: $1.23
Average Daily Volume: 117,416
Days Low: $1.17
Year Low: $0.83
Year High: $4.69
AIkido Pharma Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2021 | SPEX | AIkido Pharma Inc. | Hayes Anthony | CEO | Buy | P | 0.99 | 10,000 | 9,900 | 78,430 | 68.4 K to 78.4 K (+14.61 %) |
Apr 30 2021 | SPEX | AIkido Pharma Inc. | Hayes Anthony | CEO | Buy | P | 0.99 | 10,000 | 9,900 | 68,430 | 58.4 K to 68.4 K (+17.11 %) |
Apr 23 2021 | SPEX | AIkido Pharma Inc. | Hayes Anthony | CEO | Buy | P | 0.93 | 10,000 | 9,300 | 58,430 | 48.4 K to 58.4 K (+20.65 %) |
Jan 08 2021 | SPEX | Aikido Pharma Inc. | LeMire Paul | Director | Option Exercise | A | 0.64 | 50,000 | 32,000 | 50,000 | |
Jan 08 2021 | SPEX | Aikido Pharma Inc. | VanderZanden Robert J | Director | Option Exercise | A | 0.64 | 50,000 | 32,000 | 50,000 | |
Jan 08 2021 | SPEX | Aikido Pharma Inc. | Hayes Anthony | Chief Executive Off ... | Option Exercise | A | 0.64 | 50,000 | 32,000 | 50,000 | |
Jan 08 2021 | SPEX | Aikido Pharma Inc. | LeMire Paul | Director | Option Exercise | A | 0.64 | 50,000 | 32,000 | 50,000 | |
Jan 08 2021 | SPEX | Aikido Pharma Inc. | VanderZanden Robert J | Director | Option Exercise | A | 0.64 | 50,000 | 32,000 | 50,000 | |
Jan 08 2021 | SPEX | Aikido Pharma Inc. | Hayes Anthony | Chief Executive Off ... | Option Exercise | A | 0.64 | 50,000 | 32,000 | 50,000 | |
Jan 08 2021 | SPEX | Aikido Pharma Inc. | Dudley Robert Frederick | Director | Option Exercise | A | 0.64 | 50,000 | 32,000 | 50,000 | |
Nov 20 2018 | SPEX | SPHERIX INC | LEDWICK TIM S | Director | Grant | A | 0.90 | 10,000 | 9,000 | 30,000 | 20 K to 30 K (+50.00 %) |
Nov 20 2018 | SPEX | SPHERIX INC | Hayes Anthony | Chief Executive Off ... | Buy | P | 0.88 | 8,000 | 7,040 | 52,183 | 44.2 K to 52.2 K (+18.11 %) |
Nov 20 2018 | SPEX | SPHERIX INC | Hayes Anthony | Chief Executive Off ... | Buy | P | 0.90 | 2,000 | 1,800 | 44,183 | 42.2 K to 44.2 K (+4.74 %) |
May 07 2018 | SPEX | SPHERIX INC | Blattner Gregory James | Director | Option Exercise | A | 1.04 | 50,000 | 52,000 | 50,000 | |
May 07 2018 | SPEX | SPHERIX INC | Blattner Gregory James | Director | Option Exercise | A | 1.04 | 50,000 | 52,000 | 50,000 |